StoneX Group Inc.
Source: SEC Form 13F · as of Mar 2026StoneX Group Inc. holds 9 biotech & pharma companies tracked by BioSniper, totaling $751K in value as of Mar 2026 (SEC Form 13F).
Companies held
9
Total value held
$751K
BioSniper AIPage evidence connected
Prepared research question
What matters most for Harmony Biosciences Holdings, Inc. (HRMY)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| HRMYHarmony Biosciences Holdings, Inc. | 12,631 | $354K |
| GILDGILEAD SCIENCES, INC. | 2,518 | $351K |
| RDHLRedHill Biopharma Ltd. | 14,481 | $11K |
| HUMAHumacyte Inc. | 16,205 | $10K |
| VTGNVistagen Therapeutics, Inc. | 15,198 | $9K |
| AZTRAzitra, Inc. | 22,464 | $5K |
| BCABBioAtla, Inc. | 29,466 | $5K |
| TOVXTheriva Biologics, Inc. | 22,280 | $4K |
| OTLKOutlook Therapeutics, Inc. | 13,122 | $3K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.